Ramosetron (Iribo)
Revision as of 03:25, 18 November 2017 by Warner-admin (talk | contribs) (Text replacement - "5HT3" to "5-HT3")
Mechanism of action
Serotonin 5-HT3 receptor antagonist with antiemetic properties. No known antineoplastic properties.
History of FDA approval
Not FDA-approved; available in Japan and Southeast Asia.
Also known as
IBset, Nasea, Nozia